Lassie

AI automates dental billing in seconds

San Francisco, CA, Sweden

Other Claims/Revenue Cycle AI Billing & Coding

Lassie is a pet insurance technology company.

Shareable draft

Check out Lassie on @MedStartr Today Lassie is a pet insurance technology company. #Other #ClaimsRevenueCycleAI #BillingCoding #MedMo #MedStartrVentures

https://www.medstartr.ai/s/e1SNjWN5Cxw

Get Involved in Lassie

How We Help

Problem Statement

Lassie solves the problem of inefficient healthcare administration by automating tasks such as insurance accounts receivable (AR) reconciliation, EOB (Explanation of Benefits) posting, managing denials, and patient billing for medical practices.

Core Technology

AI-powered automation, specifically agentic AI, designed to handle and streamline various administrative and financial workflows in healthcare practices. This includes growth and onboarding infrastructure, data pipelines processing over $1 billion in insurance claims, and a sync engine backed by encrypted SQLite.

Key Differentiators

Lassie differentiates itself with a 'Consumer product DNA' applied to healthcare, focusing on product quality and customer delight; a 'wedge product' strategy concentrating on high-value problems like automating insurance payment reconciliation; and concierge support.

Target Customers

Independent medical practices, primarily dental offices and independent doctor-owners.

Product Stage

Mature

Company Info

Business Model: B2B
Founded: 2020
Website: golassie.com

Technologies

AI-powered AutomationData PipelinesAgentic AI

Clinical & IP

🔬

Clinical Validation

Trusted by 1,000+ dental practices; automates 90% of insurance payments accurately

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Lassie?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.